A few days ago, I wrote a post asserting that the preclinical research report on my intratumoral chlorine dioxide therapy is a paper worthy of a Nobel Prize.
Please have a look at this article on the Day Tapes, from 1968/69. Under the heading "Suppressing Cancer Cures as a means of poulation control" It states - "Cancer. He said. "We can cure almost every cancer right now. Information is on file in the Rockefeller Institute, if it's ever decided that it should be released. But consider - if people stop dying of cancer, how rapidly we would become overpopulated. You may as well die of cancer as something else." It goes on to say more which you can read here and you'll realise who and what you are up against. sagehana.substack.com/p/everything-is-in-place-and-nobody
I believe that no group or force would deliberately hide a cure for cancer in order to reduce the population (distinguishing this from China's family planning policy, which may benefit society). A treatment capable of curing cancer would generate enormous economic benefits that no one could ignore. Please take a look at the financial projections for my cancer therapy in the future:
### Assumptions
#### Cancer Patient Data:
- According to the Global Cancer Observatory (GLOBOCAN), approximately **20,000,000 new cancer cases** are diagnosed worldwide each year.
- The total number of cancer survivors globally (based on a 5- to 10-year survival period) is approximately **60,000,000**.
#### Target Mapping for Your Drug:
- At a **50% penetration rate**, the drug would cover **10,000,000 patients annually**.
- At a **30% penetration rate**, the drug would cover **6,000,000 patients annually**.
#### Pricing Based on Global Minimums (Excluding Hospital, Physician, and Equipment Costs):
- Global uniform pricing logic by region, excluding non-drug treatment revenue and based on minimum pricing:
| Region | Unified Pricing (USD) |
|----------------------|------------------------|
| United States | $500,000 |
| China | $70,000 |
| Europe | $400,000 |
| Japan | $280,000 |
| Other Developed Markets | $250,000 |
| Middle-Income Countries | $50,000 |
| Low-Income Countries | $5,000 |
#### Global Cancer Patient Distribution and Pricing Stratification:
- According to international cancer statistics, the distribution of cancer patients correlates with economic development levels:
| Region | Proportion of Global Cases | New Cases Per Year |
#### Profit Margin for Single-Treatment Drug Manufacturing and Distribution:
- The gross profit margin for one-time treatment drug manufacturing and distribution is conservatively estimated at **80%** (high-value patented drugs typically have a gross margin between 70%-90%).
- The above margin is calculated after deducting production, logistics, and administrative costs.
---
### Global Revenue Projections
#### At a 50% Penetration Rate:
- Target patient count = 50% of new cancer cases annually → **10,000,000 patients**.
1. **Profitability:** Even at a 30% penetration rate, the potential annual profit of the drug exceeds **$900 billion USD**, sufficient to support further R&D and marketing activities while delivering exceptional shareholder value.
2. **Broad Accessibility:** By excluding hospital and equipment revenue and basing pricing on global minimums, your drug can benefit the majority of cancer patients worldwide while maintaining sustainable profitability.
Yes, I have the contact information for these clinics. As the inventor, I can evaluate the patient. Currently, it appears that the vast majority of solid tumors are suitable for my intratumoral chlorine dioxide injection therapy.
I'm in UK, so Germany would be the nearest place. I've just heard about a woman, local to me, diagnosed with terminal lung cancer and I will hopefully make contact and tell her about your amazing work and other treatments too. I've no idea if she has the fast growing type resulting from certain medical interventions foisted on people these past years, which usual treatments do not seem to work. Are any of your patients from this "turbo cancer" group, younger people, when first diagnosed, already Stage 4?
Lung cancer is relatively complex and requires CT guidance. Currently, the clinic in Germany does not have CT equipment. If lung cancer patients still have tumors in their lungs, they need to go to the clinic in Mexico for treatment, or wait for six months until we add CT equipment to the clinic in Germany.
As for "turbo cancer," I think it is difficult to determine. We do not have many cases at the moment, but all cancer occurrences were before 2020. Therefore, it should not be the "turbo cancer" you mentioned.
Sadly, anything that cures cancer that does not generate huge profits for Big Pharma will be viciously attacked and rejected, even it means that people will die.
This is a good idea, but I’m not sure how to send him this information. Moreover, I suspect he won’t have the chance to see my message, even if I manage to send it to him.
Great and civilizational changing work, Xuewu! It’s too bad and sickening that profits reign supreme in our messed up world!
Yes, this is a system full of self-righteousness and selfishness.
Please have a look at this article on the Day Tapes, from 1968/69. Under the heading "Suppressing Cancer Cures as a means of poulation control" It states - "Cancer. He said. "We can cure almost every cancer right now. Information is on file in the Rockefeller Institute, if it's ever decided that it should be released. But consider - if people stop dying of cancer, how rapidly we would become overpopulated. You may as well die of cancer as something else." It goes on to say more which you can read here and you'll realise who and what you are up against. sagehana.substack.com/p/everything-is-in-place-and-nobody
I believe that no group or force would deliberately hide a cure for cancer in order to reduce the population (distinguishing this from China's family planning policy, which may benefit society). A treatment capable of curing cancer would generate enormous economic benefits that no one could ignore. Please take a look at the financial projections for my cancer therapy in the future:
### Assumptions
#### Cancer Patient Data:
- According to the Global Cancer Observatory (GLOBOCAN), approximately **20,000,000 new cancer cases** are diagnosed worldwide each year.
- The total number of cancer survivors globally (based on a 5- to 10-year survival period) is approximately **60,000,000**.
#### Target Mapping for Your Drug:
- At a **50% penetration rate**, the drug would cover **10,000,000 patients annually**.
- At a **30% penetration rate**, the drug would cover **6,000,000 patients annually**.
#### Pricing Based on Global Minimums (Excluding Hospital, Physician, and Equipment Costs):
- Global uniform pricing logic by region, excluding non-drug treatment revenue and based on minimum pricing:
| Region | Unified Pricing (USD) |
|----------------------|------------------------|
| United States | $500,000 |
| China | $70,000 |
| Europe | $400,000 |
| Japan | $280,000 |
| Other Developed Markets | $250,000 |
| Middle-Income Countries | $50,000 |
| Low-Income Countries | $5,000 |
#### Global Cancer Patient Distribution and Pricing Stratification:
- According to international cancer statistics, the distribution of cancer patients correlates with economic development levels:
| Region | Proportion of Global Cases | New Cases Per Year |
|----------------------|----------------------------|--------------------|
| United States | ~10% | 2,000,000 |
| China | ~24% | 4,800,000 |
| Europe | ~20% | 4,000,000 |
| Japan | ~5% | 1,000,000 |
| Other Developed Markets | ~6% | 1,200,000 |
| Middle-Income Countries | ~25% | 5,000,000 |
| Low-Income Countries | ~10% | 2,000,000 |
#### Profit Margin for Single-Treatment Drug Manufacturing and Distribution:
- The gross profit margin for one-time treatment drug manufacturing and distribution is conservatively estimated at **80%** (high-value patented drugs typically have a gross margin between 70%-90%).
- The above margin is calculated after deducting production, logistics, and administrative costs.
---
### Global Revenue Projections
#### At a 50% Penetration Rate:
- Target patient count = 50% of new cancer cases annually → **10,000,000 patients**.
| Region | Patients (50% Penetration) | Price (USD) | Revenue (USD) | Profit (80% Margin) |
|----------------------|----------------------------|-------------|---------------------|--------------------------|
| United States | 1,000,000 | $500,000 | $500,000,000,000 | $400,000,000,000 |
| China | 2,400,000 | $70,000 | $168,000,000,000 | $134,400,000,000 |
| Europe | 2,000,000 | $400,000 | $800,000,000,000 | $640,000,000,000 |
| Japan | 500,000 | $280,000 | $140,000,000,000 | $112,000,000,000 |
| Other Developed Markets | 600,000 | $250,000 | $150,000,000,000 | $120,000,000,000 |
| Middle-Income Countries | 2,500,000 | $50,000 | $125,000,000,000 | $100,000,000,000 |
| Low-Income Countries | 1,000,000 | $5,000 | $5,000,000,000 | $4,000,000,000 |
- **Global Total Revenue (50% Penetration):** $1,888,000,000,000/year (1.888 trillion USD)
- **Global Total Profit (50% Penetration):** $1,510,400,000,000/year (1.5104 trillion USD)
#### At a 30% Penetration Rate:
- Target patient count = 30% of new cancer cases annually → **6,000,000 patients**.
| Region | Patients (30% Penetration) | Price (USD) | Revenue (USD) | Profit (80% Margin) |
|----------------------|----------------------------|-------------|---------------------|--------------------------|
| United States | 600,000 | $500,000 | $300,000,000,000 | $240,000,000,000 |
| China | 1,440,000 | $70,000 | $100,800,000,000 | $80,640,000,000 |
| Europe | 1,200,000 | $400,000 | $480,000,000,000 | $384,000,000,000 |
| Japan | 300,000 | $280,000 | $84,000,000,000 | $67,200,000,000 |
| Other Developed Markets | 360,000 | $250,000 | $90,000,000,000 | $72,000,000,000 |
| Middle-Income Countries | 1,500,000 | $50,000 | $75,000,000,000 | $60,000,000,000 |
| Low-Income Countries | 600,000 | $5,000 | $3,000,000,000 | $2,400,000,000 |
- **Global Total Revenue (30% Penetration):** $1,132,800,000,000/year (1.1328 trillion USD)
- **Global Total Profit (30% Penetration):** $906,240,000,000/year (906.24 billion USD)
---
### Summary of Results
| Penetration Rate | Revenue (USD) | Profit (USD) |
|-------------------|------------------------|-------------------------|
| 50% | $1,888,000,000,000 | $1,510,400,000,000 |
| 30% | $1,132,800,000,000 | $906,240,000,000 |
---
### Analysis
1. **Profitability:** Even at a 30% penetration rate, the potential annual profit of the drug exceeds **$900 billion USD**, sufficient to support further R&D and marketing activities while delivering exceptional shareholder value.
2. **Broad Accessibility:** By excluding hospital and equipment revenue and basing pricing on global minimums, your drug can benefit the majority of cancer patients worldwide while maintaining sustainable profitability.
Have you got addresses/contact info for these clinics and how does one be assessed as suitable and become a patient/trial subject?
Yes, I have the contact information for these clinics. As the inventor, I can evaluate the patient. Currently, it appears that the vast majority of solid tumors are suitable for my intratumoral chlorine dioxide injection therapy.
I'm in UK, so Germany would be the nearest place. I've just heard about a woman, local to me, diagnosed with terminal lung cancer and I will hopefully make contact and tell her about your amazing work and other treatments too. I've no idea if she has the fast growing type resulting from certain medical interventions foisted on people these past years, which usual treatments do not seem to work. Are any of your patients from this "turbo cancer" group, younger people, when first diagnosed, already Stage 4?
Lung cancer is relatively complex and requires CT guidance. Currently, the clinic in Germany does not have CT equipment. If lung cancer patients still have tumors in their lungs, they need to go to the clinic in Mexico for treatment, or wait for six months until we add CT equipment to the clinic in Germany.
As for "turbo cancer," I think it is difficult to determine. We do not have many cases at the moment, but all cancer occurrences were before 2020. Therefore, it should not be the "turbo cancer" you mentioned.
Thanks for your swift reply.
Sadly, anything that cures cancer that does not generate huge profits for Big Pharma will be viciously attacked and rejected, even it means that people will die.
Xuewu can you send this to RFK... our new Secretary of Health. It seems this should be foremost important with all the Turbo cancers out there.
This is a good idea, but I’m not sure how to send him this information. Moreover, I suspect he won’t have the chance to see my message, even if I manage to send it to him.
Perhaps one route would be to contact an individual or organization that is in close contact with.